Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
28 Leser
Artikel bewerten:
(0)

Global Bioinformatics Markets Report 2016-2020 - Genomic Sequencing, Drug Design & Proteomics Market Size, Strategy and Forecasts

DUBLIN, Dec. 10, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/pht44l/bioinformatics) has announced the addition of the "Bioinformatics Markets - Global Market Size, Strategy and Forecasts - 2016 to 2020" report to their offering.

This new Bioinformatics sector of the biotechnology industry is poised for record growth. New technologies, people and services will be needed to help interpret the meaning of genetic information: for people, for animals and for plants. It is creating new opportunities for the next stage of the genomics revolution where information analysis and data processing technologies take the spotlight.

The market is still in its infancy but has outstanding growth potential. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country. The report includes detailed breakouts for 18 Market Segments.

Genomic Sequencing? Drug Design? Proteomics? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

Key Topics Covered:

1. Introduction and Market Definition1.1 What is Bioinformatics?1.2 The Genetics Revolution1.3 Market Definition

2. Market Overview

2.1 Market Participants

2.2 Bioinformatics Technology Overview

3. The Bioinformatics Market3.1 Market Segmentation Discussion3.2 End User Segments3.3 Product Segments3.4 Application Segments

4. Profiles of Key Bioinformatics Companies

4.1 Affymetrix, Inc.

4.2 Agena Bioscience, Inc.

4.3 Agilent Technologies

4.4 Applied Biological Materials

4.5 Biomax Informatics AG

4.6 Dassault Systemes

4.7 Dnanexus, Inc.

4.8 Geneva Bioinformatics (Genebio) SA

4.9 ID Business Solutions Ltd.

4.10 Instem, PLC

4.11 Illumina, Inc.

4.12 Integromics S.L.

4.13 Qiagen

4.14 Non Linear Dynamics Ltd.

4.15 Perkinelmer, Inc.

5. Market Issues and Trends5.1 Factors Driving Growth5.2 Factors Limiting Growth5.3 The Genetic Information Puzzle - The Heart of Bioinformatics5.4 Biotechnology Development

6. Bioinformatics Recent Developments

6.1 Recent Developments - Importance and How to Use This Section

6.2 Agilent Technologies backs new life science research center at Carleton University

6.3 WuXi PharmaTech Announces Third-Quarter 2015 Results

6.4 Ceres Announces KWS to Evaluate Bioinformatics Technology

6.5 Qiagen Announces Launch of New Bioinformatics Solution for Hereditary Diseases

6.6 Computer Sciences Will Combine CSGov Unit with SRA

6.7 NeoGenomics to Acquire GE's Clarient in Cash, Stock Deal

6.8 OpGen to Acquire AdvanDx, Inc.

6.9 CollabRx, Medytox Reach Merger Agreement

6.10 MediSapiens Ltd Introduces Bioinformatics Solution

6.11 Bioinformatics Startup Computomics Raises 500,000

6.12 FDA starts beta-testing 'the most advanced bioinformatics platform in the world'

6.13 Genomenon breaks through bioinformatics bottleneck

6.14 MediSapiens Introduces Bioinformatics Solution

6.15 AstraZeneca commits $18M to clinical trial bioinformatics collaboration

6.16 Selvita Spins Out Bioinformatics Business Into Subsidiary Ardigen

6.17 Deep Genomics Launches First Product for Bioinformatics Market

6.18 SCIEX Announces Exclusive Reseller Agreement with Advaita Bioinformatics

6.19 New Standard for Sharing Bioinformatics Tools and Workflows

6.20 Vermillion raises $18.8M to fund escalation of bioinformatics ambitions

6.21 Aeon Clinical Laboratories Leverages PierianDx Bioinformatics Platform to Enhance Genomic Test Offering

6.22 Bioinformatics tool rapidly verifies prostate cancer biomarkers

6.23 Broad Institute, Google Genomics combine bioinformatics and computing

6.24 MedBioinformatics project receives 3.5 million euros in funding

6.25 Genome Canada Announces $11 million in New Funding

6.26 Rosetta Genomics Reports Third Quarter 2015 Financial Results

6.27 UT Southwestern snags $5.6M grant to boost bioinformatics

6.28 Molecular Diagnostics Laboratories Partners with PierianDx

6.29 LifeMap Sciences' Bioinformatics Tools Licensed by SciLifeLab

7. Market Sizes, Forecasts & Growth Rates - Sectors7.1 Medical7.2 Agriculture7.3 Academic and Research Markets7.4 Other

8. Market Sizes, Forecasts & Growth Rates - Products

8.1 Instrumentation

8.2 Content Management

8.3 Bioinformatics Services

9. Market Sizes, Forecasts & Growth Rates - Applications9.1 Applications

10. Global Market Summary

10.1 Global

10.2 Potential Market Opportunity Sizes

10.3 Potential Market Sizes by Country Selected Segments

Companies Mentioned

- Advaita Bioinformatics

- AdvanDx, Inc.

- Aeon Clinical Laboratories

- Affymetrix, Inc.

- Agena Bioscience, Inc.

- Agilent Technologies

- Applied Biological Materials

- Ardigen

- AstraZeneca

- Biomax Informatics AG

- Broad Institute

- Ceres

- Clarient Inc

- CollabRx

- Computomics

- Dassault Systemes

- Dnanexus, Inc.

- Geneva Bioinformatics (Genebio) SA

- Genome Canada

- Genomenon

- Google

- ID Business Solutions Ltd.

- Illumina, Inc.

- Instem, PLC

- Integromics S.L.

- LifeMap Sciences

- MedBioinformatics

- MediSapiens Ltd

- Medytox

- NeoGenomics

- Non Linear Dynamics Ltd.

- OpGen

- Perkinelmer, Inc.

- PierianDx

- Qiagen

- Rosetta Genomics

- SCIEX

- SciLifeLab

- Selvita

- UT Southwestern

- Vermillion

- WuXi PharmaTech

For more information visit

http://www.researchandmarkets.com/research/pht44l/bioinformatics

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.